How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.

BioDrugs · 2015 · PMC4561997 · PMID 26169209

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

epoetin alpha users without any prescription within the previous 6 months) were treated with biosimilars of epoetin alpha, with an increasing trend as compared with the previous years (+71.6 %) [ 8 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.